India initiates anti-dumping probe into import of polyethylene from 6 countries
The applicant has alleged that the industry is impacted due to the dumped imports of Linear-Density Polyethylene (LLDPE).
It is primarily used in raw materials for the plastic processing industry to make a variety of products such as packaging films, profiles, wire and cable.
According to the DGTR's notification, the applicant has provided evidence with respect to the injury suffered by the domestic industry due to the dumped imports.
"The authority hereby initiates an anti-dumping investigation to determine the existence, degree and effect of the dumping," it said.
If it is established that the dumping has caused material injury to domestic players, the DGTR would recommend the imposition of the levy on imports.
The finance ministry takes the final decision to impose duties.
Anti-dumping probes are conducted by countries to determine whether domestic industries have been hurt because of a surge in cheap imports.
As a countermeasure, they impose these duties under the multilateral regime of the Geneva-based World Trade Organization (WTO). The duty is aimed at ensuring fair trading practices and creating a level playing field for domestic producers vis-a-vis foreign producers and exporters.
India and these countries are members of the WTO.
India has already imposed anti-dumping duties on several products to tackle cheap imports from various countries, including China.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
TikTok new app coming for U.S users, claim reports. Check launch date, how to download
TikTok is reportedly developing a new version of its app or users in the US as the deadline for China-based ByteDance to divest the U.S. assets nears. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads FAQs Americans are reportedly set to get a new version of TikTok as the China-based ByteDance video sharing platform is building a new version of its app for users in the United States, Reuters reported quoting The Information report. This comes ahead of a planned sale of the app to a group of investors. US President Donald Trump has said that he will start talking to China on Monday or Tuesday about a possible TikTok deal. He said the United States "pretty much" has a deal on the sale of the TikTok short-video has developed a plan to launch the new app to U.S. app stores on September 5, the report said. Last month, Trump extended to September 17 a deadline for China-based ByteDance to divest the U.S. assets of report added that TikTok users will eventually have to download the new app to be able to continue using the service, although the existing app will work until March of next year, though the timeline could change.A deal had been in the works earlier this year to spin off TikTok's U.S. operations into a new U.S.-based firm, majority-owned and operated by U.S. investors. That was put on hold after China indicated it would not approve it following Trump's announcements of steep tariffs on Chinese said the United States will probably have to get a deal approved by did not say who the potential buyer was. The president said earlier in the week that he had found a buyer for the U.S. branch of TikTok, the popular Chinese-owned video app that faces a ban adopted by Congress over national security concerns. A 2024 law required that the app effectively be banned in the United States unless its parent company, ByteDance, sold it to a non-Chinese company. Congress was concerned that sensitive user data could end up in the hands of the Chinese was not clear if the deal would comply with some of the requirements Congress adopted for a sale of TikTok, particularly if ByteDance chose not to share the app's algorithm with the U.S. buyers. Private equity firms have been hesitant to invest in a deal without some form of indemnification.A1. Parent company of TikTok is Byte Dance.A2. Donald Trump did not say who the potential buyer was.
Time of India
2 hours ago
- Time of India
E-commerce platforms delivering pan masala & gutka in Maha: PIL
Nagpur: E-commerce platforms are delivering banned pan masala and gutka products across Maharashtra in gross violation of the state's prohibition on tobacco-mixed items, alleged a PIL filed in the Nagpur bench of Bombay high court last week. The petitioner, Bhandara-based businessman Rohan Jaiswal, claimed that he ordered tobacco-laced pan masala via the e-commerce app and had it delivered to his doorstep. The PIL alleges that despite a statewide ban on gutka and pan masala with tobacco and areca nut (supari), such products are freely available through online platforms. Jaiswal's counsel, advocate Yuvan Chougule, urged the court to initiate immediate action and prevent unlawful delivery of such hazardous substances. A division bench of Justices Nitin Sambre and Sachin Deshmukh took cognisance of the plea during a hearing on Friday. The court issued notices to the secretary of state rural development department, food and drug administration (FDA), Nagpur collector, and police commissioner. All respondents were directed to file their replies within one week. According to the PIL, on May 11, 2025, Jaiswal was browsing the e-commerce application when he found banned pan masala products being listed. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Is it legal? How to get Internet without paying a subscription? Techno Mag Undo He placed an order for one such product from a private manufacturer, which was subsequently delivered to his address. The petitioner submitted the order bill, app screenshots, and UPI transaction proof as part of evidence before the court. The petition pointed out that the Maharashtra govt, via a 2012 notification, had banned manufacture, sale, and distribution of food products containing tobacco and supari. This ban was extended in July 2024 by another year. Yet, the PIL claimed, such banned products were being delivered by e-commerce platforms, raising serious concerns over regulatory enforcement and public health. Jaiswal claimed that he filed an RTI query to ascertain which govt department granted approval for such online sale, if any, but has not received a reply yet. The PIL demands that action be taken against errant online platforms under existing food safety and public health laws. It also seeks a directive to inform all online companies operating in Maharashtra about the ban and ensure they do not facilitate the sale or delivery of gutka, pan masala, or any other tobacco-laced food item. Petitioner's Contentions - E-commerce platform delivered banned tobacco-laced pan masala despite a state-wide prohibition - The product was ordered via the app on May 11, 2025, and delivered to his home - Evidence including bill, app screenshots, and UPI payment proof submitted to court - Sale violates 2012 Maharashtra govt ban on tobacco and supari-based food products - Ban extended in July 2024, yet online delivery continues unchecked - Filed RTI seeking details of any authority permitting such sales; no response received - Argues this poses a serious threat to public health
Time of India
3 hours ago
- Time of India
Sun Pharma says working towards full regulatory resolution at 3 plants facing USFDA action
Drug major Sun Pharmaceutical Industries aims to bolster compliance across its manufacturing operations and work towards achieving full regulatory resolution at the three facilities facing USFDA action, according to Chairman and MD Dilip Shanghvi. In his address to shareholders in its annual report for 2024-25, Shanghvi said the company is facing US Food and Drug Administration (USFDA) compliance-related issues at three of its facilities. The company is facing an import alert for the Halol facility and also is in receipt of non-compliance letter for the Mohali facility , he stated. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Shape your journey in the unforgiving desert world of Arrakis! Shop Now Undo Additionally, the company's Dadra facility was accorded an Official Action Indicated (OAI) status in FY24, he noted. "We have completed the implementation of Corrective and Preventive Action (CAPA) in the Halol facility, which is currently awaiting USFDA inspection, and we are in the process of implementing CAPA at the Mohali and Dadra facilities," he added. Live Events Besides these three, all facilities remain compliant with global regulatory standards, including those of the US FDA, Shanghvi said. On the business front, he noted the company expects its R&D investment to be in the range of 6-8 per cent of sales in the current financial year, with enhanced focus on speciality products. The company aims to expand its product pipeline of global speciality products, he added. "Our R&D spend in FY26 is likely to be in the range of 6-8 per cent of sales, with increased spending expected on speciality products," Shanghvi stated. The Mumbai-based drug major invested USD 154 million on speciality products R&D in FY25. Sun Pharma reported consolidated revenues of Rs 52,041 crore in FY25, with the share of global speciality business increasing from 18 per cent in FY24 to 20 per cent in FY25 sales. The company sells speciality products like Ilumya, Winlevi, Cequa and Odomzo across markets. "We anticipate mid to high single-digit consolidated topline growth in FY26, and expect our global speciality business to continue on its growth path," Shanghvi said. Elaborating on the focus areas, he said the company plans to prepare the business for potential disruptions arising from tariffs and geopolitical issues. The company would also continue to focus on cost and operational efficiency, he added.
